| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.07 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.07 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.07 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.08 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.08 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.21 | 0.08 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.068 | 0.08 |